Use of electronic medical records in oncology outcomes research

ClinicoEconomics and Outcomes Research

Volumn 2, Issue 1, 2010, Pages 1-14

  Kanas, Gena ^a   Morimoto, Libby ^a   Mowat, Fionna ^a   O'Malley, Cynthia ^b   Fryzek, Jon ^c   Nordyke, Robert ^b  

^a EXPONENT INC   (United States)

^b AMGEN INC   (United States)

^c MEDIMMUNE   (United States)

Author keywords

Health care; Medical informatics; Outcomes; Policy

Indexed keywords

ACCURACY; ARTICLE; CANCER REGISTRY; CANCER RESEARCH; DATA BASE; DISEASE CLASSIFICATION; ELECTRONIC MEDICAL RECORD; MEDICAL INFORMATICS; MEDICAL INFORMATION SYSTEM; OUTCOMES RESEARCH; PRIVACY; RESEARCH ETHICS;

EID: 77953435411     PISSN: None     EISSN: 11786981     Source Type: Journal    
DOI: 10.2147/ceor.s8411     Document Type: Article

References (57)

1. National Center for Health Statistics. Health, United States, 2007 with Chartbook on Trends in the Health of Americans. Hyattsville, MD 2007.
2. Galligioni E, Berloffa F, Caffo O, et al. Development and daily use of an electronic oncological patient record for the total management of cancer patients: 7 years' experience. Ann Oncol. 2009;20(2):349-352.
3. Mehta NB, Partin MH. Electronic health records: a primer for practicing physicians. Cleve Clin J Med. 2007;74(11):826-830.
4. American Recovery and Reinvestment Act of 2009. http://www.gpo.gov/fdsys/pkg/PLAW-111publ5/content-detail.html. accessed Feb 23, 2009.
5. Burt CW, Sisk JE. Which physicians and practices are using electronic medical records? Health Aff (Millwood). 2005;24(5):1334-1343.
6. Thakkar M, Davis DC. Risks, barriers, and benefits of EHR systems: a comparative study based on size of hospital. Perspect Health Inf Manag. 2006;3:5.
7. Baron RJ, Fabens EL, Schiffman M, Wolf E. Electronic health records: just around the corner? Or over the cliff? Ann Intern Med. 2005;143(3): 222-226.
8. Dean BB, Lam J, Natoli JL, Butler Q, Aguilar D, Nordyke RJ. Use of electronic medical records for health outcomes research: A literature review. Med Care Res Rev. 2009;66(6):611-638.
9. Huertas Fernandez MJ, Baena-Canada JM, Martinez Bautista MJ, Arriola Arellano E, Garcia Palacios MV. Impact of computerized chemotherapy prescriptions on the prevention of medication errors. Clin Transl Oncol. 2006;8(11):821-825.
10. Schmier JK, Halpern MT. Patient recall and recall bias of health state and health status. Expert Rev Pharmacoecon Outcomes Res. 2004; 4(2):159-163.
11. Cardoso F, Di LA, Lohrisch C, Bernard C, Ferreira F, Piccart MJ. Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades? Ann Oncol. 2002;13(2): 197-207.
12. Donovan KA, Greene PG, Shuster JL, Partridge EE, Tucker DC. Treatment preferences in recurrent ovarian cancer. Gynecol Oncol. 2002;86(2):200-211.
13. Penson RT, Dignan F, Seiden MV, et al. Attitudes to chemotherapy in patients with ovarian cancer. Gynecol Oncol. 2004;94(2):427-435.
14. Osoba D. Lessons learned from measuring health-related quality of life in oncology. J Clin Oncol. 1994;12(3):608-616.
15. Weeks JC, Cook EF, O'Day SJ, et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA. 1998;279(21):1709-1714.
16. Schmier JK, Kane DW, Halpern MT. Practical applications of usability theory to electronic data collection for clinical trials. Contemp Clin Trials. 2005;26(3):376-385.
17. Institute of Medicine (IOM). Knowing What Works in Health Care: A Roadmap for the Nation. Washington, DC: The National Academies Press; 2008.
18. Agency for Healthcare Research and Quality. Effective Health Care. URL: effectivehealthcare.ahrq.gov, accessed February 17, 2009.
19. Congressional Budget Office. Research on the Comparative Effectiveness of Medical Treatments: Issues and Options for an Expanded Federal Role; 2007 December. http://www.cbo.gov/doc.cfm?index=8891.accessed Feb 23, 2009.
20. Health Disparities Collaboratives (HDC) URL: http://www.healthdisparities.net/hdc/html/collaborativesOverview.aspx. Accessed June 25, 2008.
21. Healthy People 2010: Understanding and Improving Health. 2nd ed. In: US Deprtment of Health and Human Services, 23 Aug, 2000. US Government Printing Office; 2000.
22. Strategic research plan to reduce and ultimately eliminate health disparities, fiscal years 2002-2006. 2002. http://ncmhd.nih.gov/our_programs/strategic/pubs/VolumeI_031003EDrev.pdf. Accessed June 25, 2008.
23. Lisovicz N, Wynn T, Fouad M, Partridge EE. Cancer health disparities: what we have done. Am J Med Sci. 2008;335(4):254-259.
24. The NCI Strategic Plan for Leading the Nation to Eliminate the Suffereing and Death Due to Cancer. In: Institute NC, ed NIH Publication No. 06-5773. US Department of Health and Human Services, National Institutes of Health; 2006.
25. Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003; 163(1):49-56.
26. Gross CP, Smith BD, Wolf E, Andersen M. Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? Cancer. 2008;112(4):900-908.
27. Hayrinen K, Saranto K, Nykanen P. Definition, structure, content, use and impacts of electronic health records: a review of the research literature. Int J Med Inform. 2008;77(5):291-304.
28. Ambinder EP. A history of the shift toward full computerization of medicine. J Oncol Pract. 2005;1(2):54-56.
29. Ambinder E. electronic health records. J Oncol Pract. 2005;1(2): 57-63.
30. ASCO Electronic Health Record Roundtable. Ensuring continuity of care through electronic health records. J Oncol Pract. 2007;3(3): 137-142.
31. Aschengrau A, Seage GR. Essentials of Epidemiology in Public Health. Boston: Jones and Bartlett Pub; 2003
32. Goldwein J. Using an electronic health record for research. J Oncol Pract. 2007;3(5):278-279.
33. ASCO Develops Practical Guide for Selecting, Implementing Electronic Health Records. ASCO Daily News. 2008:24B.
34. Detmer D, Bloomrosen M, Raymond B, Tang P. Integrated personal health records: transformative tools for consumer-centric care. BMC Med Inform Decis Mak. 2008;8:45.
35. Weiner MG, Lyman JA, Murphy S, Weiner M. Electronic health records: high-quality electronic data for higher-quality clinical research. Inform Prim Care. 2007;15(2):121-127.
36. Pakhomov S, Weston SA, Jacobsen SJ, Chute CG, Meverden R, Roger VL. Electronic medical records for clinical research: application to the identification of heart failure. Am J Manag Care. 2007;13(6 Part 1):281-288.
37. Smith PC, Araya-Guerra R, Bublitz C, et al. Missing clinical information during primary care visits. JAMA. 2005;293(5):565-571.
38. Department of Health and Human Services. Protection of Human Subjects. 45 CFR 46. 2008;128-140. http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm. accessed Feb 23, 2009.
39. Health Insurance Portability and Accountability Act of 1996 (HIPAA), PL 104-191-2003.
40. Wolf LE, Walden JF, Lo B. Human subjects issues and IRB review in practice-based research. Ann Fam Med. 2005;3 Suppl 1:S30-S37.
41. Bush GW. Exec. Order No. 13335: Incentives for the Use of Health Information Technology and Establishing the Position of the National Health Information Technology Coordinator40. Weekly Compilation of Presidential Documents; 2004:702-704.
42. Food and Drug Administration. FDA's Critical Path Initiative. URL: http://www.fda.gov/oc/initiatives/criticalpath/. Accessed February 23, 2009.
43. Food and Drug Administration. The Sentinel Initiative, National Strategy for Monitoring Medical Product Safety: Department of Health and Human Services; May 2008.
44. US Department of Health and Human Services. Achieving a Transformed and Modernized Health Care System for the 21st Century: CMS Strategic Action Plan 2006-2009 October 16, 2006.
45. Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med. 1999;106(5):574-582.
46. Hebert-Croteau N. A meta-analysis of hormone replacement therapy and colon cancer in women. Cancer Epidemiol Biomarkers Prev. 1998;7(8):653-659.
47. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med. 2004;350(10):991-1004.
48. Chan JA, Meyerhardt JA, Chan AT, Giovannucci EL, Colditz GA, Fuchs CS. Hormone replacement therapy and survival after colorectal cancer diagnosis. J Clin Oncol. 2006;24(36):5680-5686.
49. Slattery ML, Anderson K, Samowitz W, et al. Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer (USA). Cancer Causes Control. 1999;10(5):467-473.
50. Ritenbaugh C, Stanford JL, Wu L, et al. Conjugated equine estrogens and colorectal cancer incidence and survival: The Women's Health Initiative Randomized Clinical Trial. Cancer Epidemiol Biomarkers Prev. 2008;17(10):2609-2618.
51. Chen YC, Hunter DJ. Molecular epidemiology of cancer. CA Cancer J Clin. 2005;55(1):45-54; quiz 57.
52. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98(19):10869-10874
53. Bidard FC, Conforti R, Boulet T, Michiels S, Delaloge S, Andre F. Does triple-negative phenotype accurately identify basal-like tumour? An immunohistochemical analysis based on 143 'triple-negative' breast cancers. Ann Oncol. 2007;18(7):1285-1286.
54. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295(21):2492-2502.
55. Kim MJ, Ro JY, Ahn SH, Kim HH, Kim SB, Gong G. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes. Hum Pathol. 2006;37(9):1217-1226.
56. Cleator S, Heller W, Coombes RC. Triple-negative breast cancer: therapeutic options. Lancet Oncol. 2007;8(3):235-244.
57. Sorlie T, Perou CM, Fan C, et al. Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer. Mol Cancer Ther. 2006;5(11):2914-2918.